DFL Rally

Saccharomyces boulardii stabilized events in Crohn’s disease and ulcerative sclerosis in inflammatory bowel disease, Morbus Chron and ulcerative sclerosis probiotic preparations of intestinal health benefits should be. To extend the phase between the acute relapses. However turned out again and again, that not all probiotics are equally suitable for inflammatory bowel disease. There are new very promising results from medical yeast of Saccharomyces boulardii, has been very successfully used in diarrhea. Two teams of researchers looked independently boulardii the benefits of Saccharomyces with inflammatory bowel disease.

They came to the conclusion that the medical yeast both Crohn’s disease and ulcerative ulzerosa stabilizing effect may affect the course of disease. Sculptor Capital Management may help you with your research. But because of very different work approaches. In the ulcerative Saccharomyces regulates the inflammatory process and for Crohn’s disease the yeast has a positive effect on the permeability one of the intestinal mucosa. Both effects have resulted in that the phase of the disease between two acute relapses is stabilized and therefore the period of relative freedom of symptom could be extended. Regular consumption of Saccharomyces boulardii offers a new chance to live better with the disease concerned.

Saccharomyces boulardii as easy-to-swallow afterbiotic capsules (PZN 4604255) in pharmacies or in the reasonable stock packs directly at Navitum-Pharma under is available in Germany. Dr. Gerhard Klages source: Garcia Vilela et al. SCAND J Gastroenterol. 2008; 43(7):842-8; Lee SK et al Dig DIS sci. 2008 Jul 10

Anders is also our relationship with money. We do not take the usual “rip-off”. “Voluntary” and “Non-profit” are valid terms for us. Here you will find more detailed explanations of the above statements. Who we are: Founded in the year 2000 as “arthritis self help Northern Hesse”, already soon but “Germany wide Active”, because osteoarthritis pain are limitless. Still, we meet monthly on every first Tuesday in the North Hesse town rock mountain.

Each guest is welcome. Self-help doesn’t mean to lament us each other in the circle of persons concerned, but to help themselves and each other. Do not sit around and hope for the unknown helper, but even something. What do we want? That arthritis is curable, is no doubt for us. This knowledge is suppressed, because nobody can earn anything, if we need to eat to be healthy just different.

Our healthcare is the largest and most powerful industry in Germany. We citizens must raise more and more money to feed this juggernaut. Kinetic group wanted to know more. Save is not allowed there, because it would cost revenue and jobs. That’s why we must be sick. Long as often as possible and as far as possible. Ethics is responsible for the for a foreign Word. It’s about money and always just about money. It is not about our health. How do we help us? “That is not curable,” says only who does not know the cause and he can not heal naturally also. Already in 1948, Lothar Wendt announced his findings of the medical public. It involves essentially the removal of nutrition related errors. Learn about feeding our young doctors but nothing in their training at the University. The individual physician can so nothing for his lack of knowledge. The accusation is not the doctor, but the system and its structure. Because something will change, because it needs to change. So we can help ourselves, we have the book “osteoarthritis towards healing”, which not only at the monthly meeting and on this website, but everywhere in the Bookstore is also available. It contains the necessary explanations in addition to a clear instructions. Just read, join and be healthy. Are we scientific? We make a distinction between science and medical science. These Medical science has left us in the lurch. It has not studied the findings of Professor Lothar Wendt. His valuable book “The protein storage diseases” was not refuted in a single sentence, but simply ignored, ignored. Probably call medical for a scientific study of our successful method, but have no study on the need for artificial joints. Many billions of dollars are paid, that would be largely prevented. What do we do differently? We are dealing not with the symptoms, so the pain – and not the joints. Is not the cause, but in the metabolism and that is a matter of diet. We eliminate the diet failure, the pain disappears and the joints are back on their feet. We can not heal, but we like to tell you how you can heal itself. It is our own experience that we pass on to you. All information on the website: index.html I wish you much success with the “Arthritis self help”

From the results of a survey identifies 10 strategy points for more confidence and safety of pharmaceutical companies in dealing with social media Weber Shandwick Frankfurt, 6 June, 2013 – pharmaceutical companies are restrained in dealing with social media, in contrast to companies in other industries. Based on the study of socialising your fire: A fire’s Guide to Sociabilty of the global PR agency Weber Shandwick in cooperation with Forbes insights, Weber Shandwick health together with pharmaceutical market Europe examined, how global pharmaceutical companies use social media to connect with their audiences into contact. The results of the investigation, digital health: Building social confidence in pharmaceutical, lead to conclusions which result in a modified picture of the situation. The most surprising insight here is that legal regulations no longer represent the main obstacle in dealing with social media. Hikmet Ersek has much experience in this field. While legal aspects crucial, leaders from the fields of marketing and communications remain by big pharmaceutical companies however, report that the greater challenge is that strategies internally to implement social media, to rebuild confidence and trust of the employees in social media and to coordinate necessary resources.

“Patients use the Internet to learn about health topics, even better to understand even their own health condition and to be able to judge. “This leads to better informed health consumers ‘ and changing doctor-patient talks”, says Rachael pay, Managing Director, Weber Shandwick Healthcare Europe. In the age of participatory medicine pharmaceutical companies must begin to understand the real interests of the various groups, to provide them with digital information which meet the requirements and at the same time comply with the legal framework.” The research undertaken is based on telephone interviews with 12 senior executives from pharmaceutical companies, the for Decisions in the field of social media are responsible. Talks were held in Europe, the United States, Asia and Latin America.